Categories: Business

Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines

The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy’s Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is currently considered impractical by the company. India faces substantial exposure as a major generic medicine exporter to the US.

The News Vista

Leave a Comment
Share
Published by
The News Vista
4 months ago

Recent Posts

3 killed after vehicle crashes into pedestrians in North Hollywood

Post Content

2 hours ago

US commerce secy was sent secret memo on Nvidia CEO’s affair with Chinese spy: Report

US commerce secretary Howard Lutnick had recieved a confidential memo revealing Nvidia's CEO, Jensen Huang's…

2 hours ago

Daily-wage worker feeds 300 strays with leftover rotis for 7 years

In the village of Bhairunda, Gautam Yadav leads a heartwarming mission as a daily-wage worker…

2 hours ago

Indian seafarer injured as projectile hits Liberia-flagged oil tanker in Persian Gulf

2 hours ago

‘De-risk, not decouple’: Bessent says US-China must cooperate on AI risks

The United States and China plan to initiate a dialogue on superintelligence risks during an…

2 hours ago

Jensen Huang backed nepotism in 2025 saying it doesn’t bother him

Jensen Huang's recent revelation of his extramarital affair raises questions regarding Nvidia's leadership trajectory. During…

2 hours ago